PPARGC1A and hypertensive disorder: (4) The ARB treatment enhanced the cardiac SIRT1 protein, as we as active SIRT1/PGC-1α pro-survival pathway (SIRT1, PGC-1α, Bcl2, and Bcl-xL) in hypertension.